Octopus Biosafety (STU:OCR) Other Current Receivables: €0.24 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OCR Octopus Biosafety STU:OCR
1 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Other Current Receivables?

Octopus Biosafety STU:OCR 1 Other Current Receivables is €0.24 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 1/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Octopus Biosafety's Other Current Receivables for the quarter that ended in Dec. 2024 was €0.24 Mil.

Octopus Biosafety's quarterly Other Current Receivables increased from Dec. 2022 (€0.22 Mil) to Dec. 2023 (€0.29 Mil) but then stayed the same from Dec. 2023 (€0.29 Mil) to Dec. 2024 (€0.24 Mil).

Octopus Biosafety's annual Other Current Receivables increased from Dec. 2022 (€0.22 Mil) to Dec. 2023 (€0.29 Mil) but then declined from Dec. 2023 (€0.29 Mil) to Dec. 2024 (€0.24 Mil).

Octopus Biosafety Other Current Receivables Related Terms

Octopus Biosafety Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Other Current Receivables Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.33 0.22 0.29 0.24

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.33 0.22 0.29 0.24
STU:OCR
1GF Score
Octopus Biosafety STU:OCR
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.24 Mil mean?
Octopus Biosafety (STU:OCR) has a Other Current Receivables of €0.24 Mil as of Dec. 2024. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Other Current Receivables too high?
Octopus Biosafety's current Other Current Receivables is €0.24 Mil. Overall, Octopus Biosafety has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Other Current Receivables compare to SNDK and DELL?
Octopus Biosafety's Other Current Receivables of €0.24 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Hardware company?
A good Other Current Receivables depends on the Hardware industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Other Current Receivables is €0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Other Current Receivables of €0.24 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Other Current Receivables is €0.24 Mil. Octopus Biosafety's overall GF Score™ is 1/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Other Current Receivables is €0.24 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • Other Current Receivables: €0.24 Mil
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 1/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
1GF Score

Get the complete analysis for STU:OCR

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value